Sequential administration of sclerostin antibody and parathyroid hormone differentially modulates fracture healing in a murine tibial osteotomy model
PLOS One · 17.07.2026 · 21 (7) · e0354181
DOI: 10.1371/journal.pone.0354181 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 17.07.2026. Verfasst von Atsushi Mihara und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan. Hauptthemen laut MEDLINE: Fracture Healing, Parathyroid Hormone, Osteotomy, Tibia. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kaken Pharmaceutical.
Abstract (Originalsprache)
Anabolic agents such as parathyroid hormone (PTH) analogs and sclerostin antibody (Scl-Ab) enhance fracture healing through distinct mechanisms, but whether the order of administration affects healing remains unclear. In a murine tibial osteotomy model, we compared PTH monotherapy (40 μg/kg), Scl-Ab monotherapy (25 mg/kg), and two sequential regimens with matched treatment duration and cumulative exposure between sequential groups: PTH followed by Scl-Ab (PTH → Scl-Ab) and Scl-Ab followed by PTH (Scl-Ab → PTH). Treatment was started on postoperative day 1, and the sequential groups changed agents after 1 week. PTH monotherapy significantly increased mineralized callus volume, whereas Scl-Ab monotherapy produced higher callus volumetric bone mineral density (vBMD) and greater mechanical strength. Among the sequential regimens, Scl-Ab → PTH resulted in significantly higher callus vBMD and ultimate load to failure than PTH → Scl-Ab, despite comparable callus volumes. Histological analysis showed a higher proportion of cartilaginous tissue in the PTH monotherapy and PTH → Scl-Ab groups, suggesting persistence of an earlier phase of endochondral ossification. These findings indicate that early Scl-Ab administration followed by PTH promotes earlier callus mineralization and mechanical recovery than the reverse sequence in this murine model. Although the study was limited primarily to early healing time points, the results suggest that the temporal sequence of anabolic signaling, rather than agent selection alone, can influence early fracture repair.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan.
- Faculty of Engineering, Yamaguchi University, Ube, Yamaguchi, Japan.
- Department of Pharmacology, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan.
ORCID-Profile: Atsushi Mihara, Kiminori Yukata, Norihiro Nishida, Tetsuya Seto
Förderung
- Kaken Pharmaceutical
Zitieren
APA
Mihara, A., Yukata, K., Nishida, N., Seto, T., Iwanaga, R., Fujii, K., Uehara, K., Saeki, Y., Ohgi, J., Tsuji, S., Asagiri, M., & Sakai, T. (2026). Sequential administration of sclerostin antibody and parathyroid hormone differentially modulates fracture healing in a murine tibial osteotomy model. PLOS One, 21(7), e0354181. https://doi.org/10.1371/journal.pone.0354181
Vancouver
Mihara A, Yukata K, Nishida N, Seto T, Iwanaga R, Fujii K, et al. Sequential administration of sclerostin antibody and parathyroid hormone differentially modulates fracture healing in a murine tibial osteotomy model. PLOS One. 2026;21(7):e0354181. doi:10.1371/journal.pone.0354181
BibTeX
@article{Mihara2026,
author = {Mihara, Atsushi and Yukata, Kiminori and Nishida, Norihiro and Seto, Tetsuya and Iwanaga, Ryuta and Fujii, Kenzo and Uehara, Kazuya and Saeki, Yuji and Ohgi, Junji and Tsuji, Shunya and Asagiri, Masataka and Sakai, Takashi},
title = {Sequential administration of sclerostin antibody and parathyroid hormone differentially modulates fracture healing in a murine tibial osteotomy model},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {7},
pages = {e0354181},
doi = {10.1371/journal.pone.0354181}
}
EUVIMED